Power Law company profile

Souzhou Ribo Life Science

Biotech & Life Sciences · Wuhan, China · Founded 2007 · IPO 2026 Unicorn

Souzhou Ribo Life Science develops nucleic acid drugs and related products based on the RNA interference technology

Valuation

$1.28B

Market cap · May/2026

Revenue

$20M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

23 investors on Souzhou Ribo Life Science's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

BVCF

Series B+ 22 investors entered at this stage

Trinity Innovation Fund

Huatai Securities

Legend Capital

DC Fund

CICC

DIMENSION

Mingxin China Growth Fund

China Asset Management

SDIC Fund Management Company

Hongtao Capital

China Resources

Peking University

Everest Venture Capital

Taikang Life Insurance

TusPark Ventures

Pan-Lin Asset Management

Bright Stone

SDIC Fund Management

SAIC Motor

Notable Capital

GL Ventures

Springs Capital

Global footprint

Where Souzhou Ribo Life Science has talent and traffic

Workforce by country

🇨🇳 China · Wuhan HQ

Book a demo for the full country breakdown

Web traffic by country

1.2K monthly visits
across markets

🇺🇸 United States100%

Top 1 markets shown

Patent intelligence

$61M patent portfolio · 73 active families

Estimated portfolio value

$61M

4.8% of market cap · 33.1× smaller than top peer Ablynx ($2B)

73 active patent families

Where Souzhou Ribo Life Science innovates Molecular biologyPharmaceutical drugNucleotideNucleic acidNucleotide sequencing

Where Souzhou Ribo Life Science concentrates vs peers

Each axis is a top-10 topic across Souzhou Ribo Life Science and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Souzhou Ribo Life Science

An AI-synthesized read of the highest-engagement posts about Souzhou Ribo Life Science on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Souzhou Ribo Life Science on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles